Notice: Function amp_is_available was called incorrectly. `amp_is_available()` (or `amp_is_request()`, formerly `is_amp_endpoint()`) was called too early and so it will not work properly. WordPress is currently doing the `init` hook. Calling this function before the `wp` action means it will not have access to `WP_Query` and the queried object to determine if it is an AMP response, thus neither the `amp_skip_post()` filter nor the AMP enabled toggle will be considered. It appears the plugin with slug `jetpack` is responsible; please contact the author. Please see Debugging in WordPress for more information. (This message was added in version 2.0.0.) in /var/www/wp-includes/functions.php on line 5835
technology – Force Pharma Capital
Skip to content
Force Pharma Capital
Force Pharma Capital
Life Science Consulting, Business Development and Recruiting/Staffing
  • Home
  • About Us
  • Services
  • Pharmaceutical Blog
    • RLD
    • Excipients
    • Equipment
    • Health Technology
    • Regulatory Fees
  • Contact Us
  • FAQ
  • Portfolio

Tag: technology

FDA approves first drug for treatment of peanut allergy for children

February 1, 2020 Blogger

FDA approves first drug for treatment of peanut allergy for children — Read on s2027422842.t.en25.com/e/es This is a huge achievement…

Continue Reading →

Posted in: Health Technology Filed under: approvals, FDA, pdufa, technology

Targeting gut bacteria to treat alcoholic hepatitis | National Institutes of Health (NIH)

December 3, 2019 Blogger

A therapy targeting bacteria that make a specific toxin lessened alcohol-associated liver disease in a mouse study. — Read on…

Continue Reading →

Posted in: Health Technology Filed under: technology

Channel in Nerve Cell May be Key in Unlocking Parkinson Disease Therapy

Blogger

Researchers have identified a channel in nerve cells that may serve as a new approach to targeting Parkinson disease. —…

Continue Reading →

Posted in: Health Technology Filed under: fixed dose combination, technology

FDA approves new breakthrough therapy for cystic fibrosis | FDA

October 21, 2019 Blogger

FDA approves breakthrough therapy Trikafta for patients 12 and older with cystic fibrosis who have at least one F508del mutation…

Continue Reading →

Posted in: Health Technology Filed under: approvals, FDA, fixed dose combination, pdufa, technology

Blocking Inflammatory Pathway May Stop Brain Metastasis from Melanoma

October 20, 2019 Blogger

Melanoma brain metastasis occurs when tumor cells hijack an inflammatory pathway in the brain and blocking this pathway could prevent…

Continue Reading →

Posted in: Health Technology Filed under: FDA, technology

Impact Story: Regulatory Science is Strengthening U.S. Drug Product Manufacturing | FDA

September 26, 2019 Blogger

FDA CDER is advancing manufacturing science to develop quicker, more reliable ways to make drugs and drug components. — Read…

Continue Reading →

Posted in: Health Technology Filed under: FDA, technology

FDA takes first action under new international collaboration with Australia and Canada designed to provide a framework for concurrent review of cancer therapies, approving treatment for patients with endometrial carcinoma | FDA

September 17, 2019 Blogger

Project Orbis provides a framework for concurrent submission and review of oncology drugs among its international partners. Under this project,…

Continue Reading →

Posted in: Health Technology Filed under: approvals, pdufa, technology

Drug Trials Snapshots: RINVOQ | FDA

September 12, 2019 Blogger

Drug Trial Snapshot — Read on www.fda.gov/drugs/resources-information-approved-drugs/drug-trials-snapshots-rinvoq Another inhibitor approved for oncology….

Continue Reading →

Posted in: Health Technology Filed under: approvals, FDA, technology

Antibiotics Administration: Factors to be Considered by Pharmacists

September 4, 2019 Blogger

In recent years, health care professionals have been seeing a surge in adverse effects associated with long-term use of antibiotics,…

Continue Reading →

Posted in: Health Technology Filed under: technology

FDA warns test companies not to tell patients about gene-drug links – STAT

August 31, 2019 Blogger

The FDA is concerned that unsupported claims about gene-drug links could be dangerous, spurring patients to start, stop, or switch…

Continue Reading →

Posted in: Health Technology Filed under: FDA, technology

Post navigation

Page 1 of 2
1 2 Next →

Recent Posts

  • Most Recent Changes to the IID Database | FDA
  • The History, Benefits of Pharmaceutical REMS Programs
  • FDA approves first drug for treatment of peanut allergy for children

Recent Comments

  • flower bouquet delivery online on FDA Grants Priority Review to Zanubrutinib for Relapsed/Refractory Mantle Cell Lymphoma
  • cheap flowers online same day delivery on Trending News Today: Investigational Long-Acting HIV Injection Shows Efficacy in Study
  • flower arrangements for baby shower girl on FDA Grants Priority Review to Zanubrutinib for Relapsed/Refractory Mantle Cell Lymphoma

Archives

  • August 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • November 2018

Follow Us

Contact Us

  • Email
    forcepharma@icloud.com
  • Phone
    732-702-1824
  • Address
    265 Route 34 Lower Level, Colts Neck, New Jersey, 07722
Copyright © 2018 Force Pharma Capital